We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Waters and Spark Holland Enter Co-marketing Agreement for High Volume Labs

By HospiMedica staff writers
Posted on 05 Mar 2007
Waters Corporation (Milford, MA, USA) and Spark Holland (Emmen, The Netherlands), have entered into a co-marketing agreement to promote an integrated solution for high volume clinical laboratories. More...
These integrated systems are comprised of Waters' mass spectrometers and Spark Holland's symbiosis on-line solid phase extraction (SPE) system under the control of Waters MassLynx mass spectrometry data acquisition, processing, and reporting software.

With this integrated system high-volume labs can now automate sample processing, analysis, and data reduction. This will enable high volume clinical and forensic laboratories worldwide to analyze samples faster, increase throughput, and lower costs.

We are pleased to enter into this co-marketing agreement with Spark Holland. We believe that the combination of on-line SPE using Waters Oasis sorbents together with our mass spectrometers is truly enabling for customers in high-throughput environments for automating and integrating sample preparation, separation, and detection, said Michael Yelle, senior director of clinical operations at Waters corporation.

"We believe that the power of the Waters mass spectrometers combined with the Symbiosis front-end automation--all controlled from a single software package--is a big step towards a fully integrated analyzer for the clinical market. Better workflow with less manual handling should improve throughput and quality of the analysis. We are excited about our co-marketing arrangement with Waters and believe it can deliver great benefits for our joint customers,” said Rob Castien, president of Spark Holland.

Waters Clinical Business Operations group is dedicated to the adoption of liquid chromatography/mass spectrometry (LC/MS) in the clinical market worldwide. Waters customers are supported by a scientific team in the United Kingdom and dedicated clinical support staff in the United States and Europe.

Spark pioneered solid phase extraction with on-line elution into high performance liquid chromatography (HPLC) and LC-MS systems in the 1980s, followed by its introduction to the market in the early 1990s. Since, the company has evolved to a world-class provider of innovative sample introduction, extraction, and separation technology for analytical systems such as HPLC, MS, gas chromatography (GC), and nuclear magnetic resonance (NMR).

Waters Corporation holds worldwide leading positions in three complementary analytical technologies--liquid chromatography, mass spectrometry, and thermal analysis.


Related Links:
Waters Corporation
Spark Holland

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.